taxonomy (6)
protein (94)
source (19)
structure (19)
composition (1)
disease (8)
reference (33)
site (135)
peptide (124)
- Homo sapiens (Human)
- Desmodus rotundus (Common vampire bat)
- Rattus norvegicus (Norway rat)
- Gallus gallus (Chicken)
- Friend murine leukemia virus (F-mulv)
- Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Taxonomy
- 4F2 cell-surface antigen heavy chain / Homo sapiens P08195
- Alpha-1-acid glycoprotein 1 / Homo sapiens P02763
- Alpha-1-acid glycoprotein 2 / Homo sapiens P19652
- Alpha-1-antichymotrypsin / Homo sapiens P01011
- Alpha-1-antitrypsin / Homo sapiens P01009
- Alpha-mannosidase 2 / Homo sapiens Q16706
- Alpha-n-acetylgalactosaminidase / Homo sapiens P17050
- Alpha-n-acetylglucosaminidase / Homo sapiens P54802
- Aminopeptidase n / Homo sapiens P15144
- Angiotensin-converting enzyme 2 / Homo sapiens Q9BYF1
- Apolipoprotein D / Homo sapiens P05090
- Apolipoprotein F / Homo sapiens Q13790
- Asporin / Homo sapiens Q9BXN1
- Attractin / Homo sapiens O75882
- BDNF/NT-3 growth factors receptor / Homo sapiens Q16620
- Biglycan / Homo sapiens P21810
- Butyrophilin subfamily 1 member A1 / Homo sapiens Q13410
- CD166 antigen / Homo sapiens Q13740
- CD16A-NK08-V/F genotype / Homo sapiens P08637
- CD16A-NK09-V/F genotype / Homo sapiens P08637
- CD16A-NK11-F/F genotype / Homo sapiens P08637
- CD16A-NK13-V/F genotype / Homo sapiens P08637
- CD276 antigen / Homo sapiens Q5ZPR3
- CD44 antigen / Homo sapiens P16070
- CD59 glycoprotein / Homo sapiens P13987
- Cell adhesion molecule 1 / Homo sapiens Q9BY67
- Ceruloplasmin / Homo sapiens P00450
- Clusterin / Homo sapiens P10909
- Complement c1r subcomponent / Homo sapiens P00736
- Complement C1r subcomponent-like protein / Homo sapiens Q9NZP8
- Decorin / Homo sapiens P07585
- Desmocollin-2 / Homo sapiens Q02487
- Endothelin-converting enzyme 1 / Homo sapiens P42892
- Epithelial cell adhesion molecule / Homo sapiens P16422
- ERO1-like protein beta / Homo sapiens Q86YB8
- Erythropoietin / Homo sapiens P01588
- Extracellular matrix protein 1 / Homo sapiens Q16610
- Fibronectin / Homo sapiens P02751
- Galectin-3-binding protein / Homo sapiens Q08380
- Haptoglobin / Homo sapiens P00738
- Hemopexin / Homo sapiens P02790
- Hepatocyte growth factor / Homo sapiens P14210
- Homeobox protein Hox-B3 / Homo sapiens P14651
- Hypoxia up-regulated protein 1 / Homo sapiens Q9Y4L1
- Immunoglobulin epsilon chain c region / Homo sapiens P01854
- Inactive tyrosine-protein kinase 7 / Homo sapiens Q13308
- Integrin alpha-L / Homo sapiens P20701
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens Q14624
- Kininogen-1 / Homo sapiens P01042
- Lactotransferrin / Homo sapiens P02788
- Laminin subunit alpha-5 / Homo sapiens O15230
- Laminin subunit beta-1 / Homo sapiens P07942
- Laminin subunit gamma-1 / Homo sapiens P11047
- Leptin receptor / Homo sapiens P48357
- Lumican / Homo sapiens P51884
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens P11279
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens P13473
- Macrophage colony-stimulating factor 1 receptor / Homo sapiens P07333
- Macrophage mannose receptor 1 / Homo sapiens P22897
- Maltase-glucoamylase, intestinal / Homo sapiens O43451
- Multimerin-1 / Homo sapiens Q13201
- Neural cell adhesion molecule L1-like protein / Homo sapiens O00533
- P-selectin / Homo sapiens P16109
- Plexin-B2 / Homo sapiens O15031
- Prolactin-inducible protein / Homo sapiens P12273
- Prolargin / Homo sapiens P51888
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens Q07954
- Prosaposin / Homo sapiens P07602
- Prostaglandin F2 receptor negative regulator / Homo sapiens Q9P2B2
- Prostaglandin-h2 d-isomerase / Homo sapiens P41222
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens P07288
- Protein heg homolog 1 / Homo sapiens Q9ULI3
- Protein-lysine 6-oxidase / Homo sapiens P28300
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens Q15262
- Secretogranin-3 / Homo sapiens Q8WXD2
- Sodium/potassium-transporting ATPase subunit beta-1 / Homo sapiens P05026
- T-cell immunomodulatory protein / Homo sapiens Q8TB96
- Target of Nesh-SH3 / Homo sapiens Q7Z7G0
- Tenascin / Homo sapiens P24821
- Tenascin-X / Homo sapiens P22105
- Thioredoxin domain-containing protein 15 / Homo sapiens Q96J42
- Thrombopoietin / Homo sapiens P40225
- Transcobalamin-1 / Homo sapiens P20061
- Trem-like transcript 2 protein / Homo sapiens Q5T2D2
- Tripeptidyl-peptidase 1 / Homo sapiens O14773
- Tyrosine-protein kinase receptor UFO / Homo sapiens P30530
- Uromodulin / Homo sapiens P07911
- Versican core protein / Homo sapiens P13611
- Voltage-dependent calcium channel subunit alpha-2/delta-1 / Homo sapiens P54289
- Salivary plasminogen activator alpha 1 / Desmodus rotundus P98119
- Neuroligin 1 / Rattus norvegicus Q62765
- Envelope glycoprotein / Friend murine leukemia virus P03395
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Blood Serum (UBERON_0001977) Mature NK T cell (CL_0000814)
- Blood Serum (UBERON_0001977)
- Bone Marrow (UBERON_0002371)
- Colon (UBERON_0001155)
- Kidney (UBERON_0002113) BHK-21 (CVCL_1914)
- Kidney (UBERON_0002113) BHK570 (CVCL_6370) Fibroblast (CL_0000057)
- Kidney (UBERON_0002113) HEK293 (CVCL_0045)
- Kidney (UBERON_0002113) HEK293-EBNA (CVCL_6974)
- Mammary Gland (UBERON_0001911)
- Milk (UBERON_0001913)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Ovary (UBERON_0000992) CHO-DG44 (CVCL_7180)
- Seminal Fluid (UBERON_0006530)
- Urine (UBERON_0001088)
- Eveline (CVCL_A1LI)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- HEK293T (CVCL_0063)
- Neutrophil (CL_0000775)
Source
- N-Linked / Complex / Structure 495
- N-Linked / Complex / Structure 1342
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-3)[Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Fuc + 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-?) + NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Gal(b1-4)GlcNAc(b1-3) + 2 x NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-?)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x NeuAc(a2-3)"
- N-Linked / Complex / Hex(?1-?)HexNAc(?1-?)[Hex(?1-?)HexNAc(?1-?)]Man(a1-3)[Hex(?1-?)HexNAc(?1-?)[Hex(?1-?)HexNAc(?1-?)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ 2 x NeuAc"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 9522
- N-Linked / Complex / Structure 10126
- N-Linked / Complex / Structure 10149
- N-Linked / Complex / Structure 10613
- N-Linked / Complex / Structure 10717
- N-Linked / Complex / Structure 10736
- N-Linked / Complex / Structure 11112
- N-Linked / Complex / Structure 11247
Reported structure
- Cancer, breast (DOID:1612)
- Control/Healthy
- COVID-19 (DOID:0080600)
- Hyper IgE syndrome (PGM3 mutation, p.Asp507Tyr) (DOID:0080545)
- IgE myeloma (DOID:9538)
- Mixed phenotype acute leukemia (DOID:9953)
- Multiple myeloma (DOID:9538)
- Prostate cancer (DOID:10283)
Disease
- Glycoproteome remodeling in MLL-rearranged B-cell precursor acute lymphoblastic leukemia. (2021 - Oliveira T, Zhang M, Joo EJ, Abdel-Azim H, Chen CW, Yang L, Chou CH, Qin X, Chen J, Alagesan K, Almeida A, Jacob F, Packer NH, von Itzstein M, Heisterkamp N, Kolarich D) / Status : Reviewed
- Aberrant sialylation in a patient with a HNF1α variant and liver adenomatosis (2021 - Luisa Sturiale, Marie-Cécile Nassogne, Angelo Palmigiano, Angela Messina, Immacolata Speciale, Rosangela Artuso, Gaetano Bertino, Nicole Revencu, Xavier Stephénne, Cristina De Castro, Gert Matthijs, Rita Barone, Jaak Jaeken, Domenico Garozzo) / Status : Reviewed
- Toward robust N-glycomics of various tissue samples that may contain glycans with unknown or unexpected structures. (2021 - Suzuki N, Abe T, Hanzawa K, Natsuka S) / Status : Reviewed
- Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor (2020 - Peng Zhao, Jeremy L. Praissman, Oliver C. Grant, Yongfei Cai, Tianshu Xiao, Katelyn E. Rosenbalm, Kazuhiro Aoki, Benjamin P. Kellman, Robert Bridger, Dan H. Barouch, Melinda A. Brindley, Nathan E. Lewis, Michael Tiemeyer, Bing Chen, Robert J. Woods, Lance Wells) / Status : Reviewed
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Cysteine Aminoethylation Enables the Site-Specific Glycosylation Analysis of Recombinant Human Erythropoietin using Trypsin (2020 - Steffen Lippold, Alexander Büttner, Matthew S.F. Choo, Michaela Hook, Coen J. de Jong, Terry Nguyen-Khuong, Markus Haberger, Dietmar Reusch, Manfred Wuhrer, Noortje de Haan) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Primary Human Natural Killer Cells Retain Proinflammatory IgG1 at the Cell Surface and Express CD16a Glycoforms with Donor-dependent Variability. (2019 - Patel KR, Nott JD, Barb AW) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- A single glycan on IgE is indispensable for initiation of anaphylaxis (2015 - Kai-Ting C. Shade, Barbara Platzer, Nathaniel Washburn, Vinidhra Mani, Yannic C. Bartsch, Michelle Conroy, Jose D. Pagan, Carlos Bosques, Thorsten R. Mempel, Edda Fiebiger, Robert M. Anthony) / Status : Reviewed
- Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels, (2014 - Atfa Sassi, Sandra Lazaroski, Gang Wu, Stuart M. Haslam, Manfred Fliegauf, Fethi Mellouli, Turkan Patiroglu, Ekrem Unal, Mehmet Akif Ozdemir, Zineb Jouhadi, Khadija Khadir, Leila Ben-Khemis, Meriem Ben-Ali, Imen Ben-Mustapha, Lamia Borchani, Dietmar Pfeifer, Thilo Jakob, Monia Khemiri, A. Charlotta Asplund, Manuela O. Gustafsson, Karin E. Lundin, Elin Falk-Sörqvist, Lotte N. Moens, Hatice Eke Gungor, Karin R. Engelhardt, Magdalena Dziadzio, Hans Stauss, Bernhard Fleckenstein, Rebecca Meier, Khairunnadiya Prayitno, Andrea Maul-Pavicic, Sandra Schaffer, Mirzokhid Rakhmanov, Philipp Henneke, Helene Kraus, Hermann Eibel, Uwe Kölsch, Sellama Nadifi, Mats Nilsson, Mohamed Bejaoui, Alejandro A. Schäffer, C.I. Edvard Smith, Anne Dell, Mohamed-Ridha Barbouche, Bodo Grimbacher) / Status : Reviewed
- Site-specific N-glycosylation analysis of human immunoglobulin E. (2014 - Plomp R, Hensbergen PJ, Rombouts Y, Zauner G, Dragan I, Koeleman CA, Deelder AM, Wuhrer M) / Status : Reviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4 (2014 - Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.) / Status : Reviewed
- Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS (2014 - Song E, Mayampurath A, Yu CY, Tang H, Mechref Y) / Status : Reviewed
- Quantitative analysis of site-specific N-glycans on sera haptoglobin β chain in liver diseases. (2013 - Zhang S, Jiang K, Sun C, Lu H, Liu Y.) / Status : Reviewed
- Determination of site-specific glycan heterogeneity on glycoproteins (2012 - Kolarich D1, Jensen PH, Altmann F, Packer NH.) / Status : Reviewed
- Structural characterization of recombinant soluble rat neuroligin 1: mapping of secondary structure and glycosylation by mass spectrometry. (2004 - Hoffman RC, Jennings LL, Tsigelny I, Comoletti D, Flynn RE, Sudhof TC, Taylor P) / Status : Reviewed
- Human alpha-N-acetylgalactosaminidase: site occupancy and structure of N-linked oligosaccharides. (2000 - Ohta M, Ohnishi T, Ioannou Y, Hodgson M, Matsuura F, Desnick R) / Status : Reviewed
- Structural determination of N-linked carbohydrates by matrix-assisted laser desorption/ionization-mass spectrometry following enzymatic release within sodium dodecyl sulfate-polyacrylamide electrophoresis gels: application to species-specific glycosylation of alpha1-acid glycoprotein. (1998 - Kuster B, Hunter A, Wheeler S, Dwek R, Harvey D) / Status : Reviewed
- Analysis of site-specific N-glycosylation of recombinant Desmodus rotundus salivary plasminogen activator rDSPA alpha 1 expressed in Chinese hamster ovary cells. (1997 - Gohlke M, Nuck R, Kannicht C, Grunow D, Baude G, Donner P, Reutter W) / Status : Reviewed
- Peptide, disulfide, and glycosylation mapping of recombinant human thrombopoietin from ser1 to Arg246. (1996 - Hoffman RC, Andersen H, Walker K, Krakover JD, Patel S, Stamm MR, Osborn SG) / Status : Reviewed
- Structural analysis of the sialylated N- and O-linked carbohydrate chains of recombinant human erythropoietin expressed in Chinese hamster ovary cells. Sialylation patterns and branch location of dimeric N-acetyllactosamine units. (1995 - Hokke C, Bergwerff A, Van Dedem G, Kamerling J, Vliegenthart J) / Status : Reviewed
- A strategy for the mapping of N-glycans by high-performance capillary electrophoresis. (1994 - Hermentin P, Doenges R, Witzel R, Hokke C, Vliegenthart J, Kamerling J, Conradt H, Nimtz M, Brazel D) / Status : Reviewed
- Structures of sialylated oligosaccharides of human erythropoietin expressed in recombinant BHK-21 cells. (1993 - Nimtz M, Martin W, Wray V, Klppel K, Augustin J, Conradt H) / Status : Reviewed
- Structural study of the N-linked oligosaccharides of hepatocyte growth factor by two-dimensional sugar mapping. (1993 - Hara H, Nakae Y, Sogabe T, Ihara I, Ueno S, Sakai H, Inoue H, Shimizu S, Nakamura T, Shimizu N) / Status : Reviewed
- Oligosaccharides at individual glycosylation sites in glycoprotein 71 of Friend murine leukemia virus. (1990 - Geyer R, Dabrowski J, Dabrowski U, Linder D, Schlter M, Schott H, Stirm S) / Status : Reviewed
Reference
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-mannosidase 2 / Homo sapiens
-
Alpha-n-acetylgalactosaminidase / Homo sapiens
- Undefined site
- Alpha-n-acetylglucosaminidase / Homo sapiens
- Aminopeptidase n / Homo sapiens
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
- Apolipoprotein D / Homo sapiens
- Apolipoprotein F / Homo sapiens
- Asporin / Homo sapiens
- Attractin / Homo sapiens
- BDNF/NT-3 growth factors receptor / Homo sapiens
- Biglycan / Homo sapiens
- Butyrophilin subfamily 1 member A1 / Homo sapiens
- CD166 antigen / Homo sapiens
- CD16A-NK08-V/F genotype / Homo sapiens
- CD16A-NK09-V/F genotype / Homo sapiens
- CD16A-NK11-F/F genotype / Homo sapiens
- CD16A-NK13-V/F genotype / Homo sapiens
- CD276 antigen / Homo sapiens
- CD44 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Cell adhesion molecule 1 / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Complement c1r subcomponent / Homo sapiens
- Complement C1r subcomponent-like protein / Homo sapiens
- Decorin / Homo sapiens
- Desmocollin-2 / Homo sapiens
- Endothelin-converting enzyme 1 / Homo sapiens
- Epithelial cell adhesion molecule / Homo sapiens
- ERO1-like protein beta / Homo sapiens
- Erythropoietin / Homo sapiens
- Extracellular matrix protein 1 / Homo sapiens
- Fibronectin / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Hepatocyte growth factor / Homo sapiens
- Homeobox protein Hox-B3 / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
- Immunoglobulin epsilon chain c region / Homo sapiens
- Inactive tyrosine-protein kinase 7 / Homo sapiens
- Integrin alpha-L / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Laminin subunit alpha-5 / Homo sapiens
- Laminin subunit beta-1 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Leptin receptor / Homo sapiens
- Lumican / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Macrophage colony-stimulating factor 1 receptor / Homo sapiens
- Macrophage mannose receptor 1 / Homo sapiens
- Maltase-glucoamylase, intestinal / Homo sapiens
- Multimerin-1 / Homo sapiens
- Neural cell adhesion molecule L1-like protein / Homo sapiens
- P-selectin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens
- Protein heg homolog 1 / Homo sapiens
- Protein-lysine 6-oxidase / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Secretogranin-3 / Homo sapiens
- Sodium/potassium-transporting ATPase subunit beta-1 / Homo sapiens
- T-cell immunomodulatory protein / Homo sapiens
- Target of Nesh-SH3 / Homo sapiens
- Tenascin / Homo sapiens
- Tenascin-X / Homo sapiens
- Thioredoxin domain-containing protein 15 / Homo sapiens
-
Thrombopoietin / Homo sapiens
- Undefined site
- Transcobalamin-1 / Homo sapiens
- Trem-like transcript 2 protein / Homo sapiens
- Tripeptidyl-peptidase 1 / Homo sapiens
- Tyrosine-protein kinase receptor UFO / Homo sapiens
- Uromodulin / Homo sapiens
- Versican core protein / Homo sapiens
- Voltage-dependent calcium channel subunit alpha-2/delta-1 / Homo sapiens
- Salivary plasminogen activator alpha 1 / Desmodus rotundus
-
Neuroligin 1 / Rattus norvegicus
- Undefined site
- Envelope glycoprotein / Friend murine leukemia virus
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- LELNLTDSENATCLYAK (17aa)
- LVPVPITNATLDR (13aa)
- LVPVPITNATLDQITGK (17aa)
- TAVNCSSDFDACLITK (16aa)
- TAVNCSSDFDACIITK (16aa)
- EAENITTGC (9aa)
- RLSPNASAEHLELRW (15aa)
- AFNSTLPTMAQMEK (14aa)
- YETTNK (6aa)
- FHNESLISSQASSY (14aa)
- CIQANYSIMENGK (13aa)
- SLNENITVPDTK (12aa)
- NKSVLLGR (8aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- YFTPNKTEDTIFLR (14aa)
- SVQEIQATFFYFTPNK (16aa)
- KSVQEIQATFFYFTPNKT (18aa)
- AEMNGSK (7aa)
- DSVINLSESVEDGPK (15aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- DPGAAVPGAANASAQQPR (18aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- KKKEDALNETRE (12aa)
- KKKEDALNETRESETKL (17aa)
- AFENVTDLQWLILDHNLLENSK (22aa)
- GSNYTSK (7aa)
- VVNITMVALK (10aa)
- QNQCFYNSSYLNVQR (15aa)
- QDQCIYNTTYINVQR (15aa)
- QDQCIYNTTYLNVQR (15aa)
- ADGTVNQIEGEATPVNITEPAKIEVK (26aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- IAVQFGPGFSWIANFTK (17aa)
- FQIINFSSSEIK (12aa)
- TCDWIPKPNMSASCK (15aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- ELPGVCNETMMALWEECK (18aa)
- NDTLLGIK (8aa)
- TFYWDFYTNR (10aa)
- GQALLVNSSQPWEPLQLHVDK (21aa)
- SANASFNIK (9aa)
- QGGVNATQVLIQHLR (15aa)
- TQSLLIVNNATNVVIK (16aa)
- MLLTFHTDFSNEENGTIMFYK (21aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- ALSNISLR (8aa)
- TINQSSDEIQISMGNAMFVK (20aa)
- SELGAVIFWGQNQTLDPNNMTILNR (25aa)
- IGAINSTISNQSK (13aa)
- HTNYSFSPWHGFTIHR (16aa)
- VYSSANNCTFE (11aa)
- GNFSTEGCGCVCEPGWK (17aa)
- CRGLVGSKNVSSE (13aa)
- NITGLENFTLK (11aa)
- SWPAVGNCSSALR (13aa)
- TVNITITQGLA (11aa)
- KNLFLNHSENATAKD (15aa)
- YNITSQDVGSGTSNNSQACAQFIEQYFHDSDIAQFMR (37aa)
- RYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMR (38aa)
- VVIGANGTYSCIVR (14aa)
- CNYSIR (6aa)
- LTVNSSNSIK (10aa)
- VEMANLLNLSER (12aa)
- VVLHPNYSQVDIGLIK (16aa)
- ISHNEIADSGIPGNSFNVSSIVEIDISYNK (30aa)
- ITNISSDDSGK (11aa)
- VFPQVNVTK (9aa)
- IININPNK (8aa)
- NAIKEGDNITIK (12aa)
- YIQPIIAVQFTNITMDTEIR (20aa)
- EGDNITIK (8aa)
- MIENGSISFIPTIR (14aa)
- LNSSTIK (7aa)
- NSSGPDLSWLHFYR (14aa)
- ITDIENGSIANIPR (14aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- NGTITDAVDCALDPLSE (17aa)
- LNAENNATFYFK (12aa)
- NQSVNVFLGHTAIDEMLK (18aa)
- YIQVVYLHNNNISVVGSSDFCPPGHNTK (28aa)
- NATGDYK (7aa)
- NICHLR (6aa)
- NETLALPAESK (11aa)
- QDFNITDISLLEHR (14aa)
- INGTQICPNDIVAFHDFSSDIENVPHIR (28aa)
- FENQTGFPPPDSR (13aa)
- RFPNIT (6aa)
- NATDNISK (8aa)
- MNDTIFGFTMEER (13aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- YKGLNLTEDTYKPR (14aa)
- VVNPTQK (7aa)
- VFHIHNESWVLLTPK (15aa)
- VNCSHPFGAFR (11aa)
- APQHVVNHLPPYTNVSLK (18aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- DQCIVDDITYNVNDTFHK (18aa)
- NGIYNITVLASDQGGR (16aa)
- YSVLIMAEKPVGDLSSPNETK (21aa)
- NSSVEAFK (8aa)
- AGCLIGAEHVNNSYE (15aa)
- NVTLLWK (7aa)
- NCMLNENMSVCVADFGLSK (19aa)
- IETILLNGTDR (11aa)
- ELHHLQEQNVSNAFLDK (17aa)
- LNDSIQTLVNDNQR (14aa)
- NATLVNEADK (10aa)
- NATIVNEADKIR (12aa)
- LSALDNLLNHSSMFLK (16aa)
- HLVNISVYAFNK (12aa)
- AATCINPINGSVCERPANHSAK (22aa)
- TQAALSNLTCCIDR (14aa)
- VPAQEKNFTTAPAICHDGKAHFPREGVF (28aa)
- NGTHWFV (7aa)
- EGVFVSNGTHWFVTQR (16aa)
- TLAGENQTAFEIEELNRK (18aa)
- LSDTTSQSNSTAK (13aa)
- VEAAQNITIPGSIR (14aa)
- IIETVEYNISGAER (14aa)
- QDPVSWDVAFVNISR (15aa)
- GFEESEPVSGSFTTAIDGPSGIVTANITDSEAIAR (35aa)
- AQQIIANSTAIEEAMIQEQQR (21aa)
- ALNLTEGFAVLHWK (14aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Blood Serum (UBERON_0001977)
- Haptoglobin / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Blood Serum (UBERON_0001977) Mature NK T cell (CL_0000814)
- Blood Serum (UBERON_0001977)
- Kidney (UBERON_0002113) HEK293 (CVCL_0045)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- HEK293 (CVCL_0045)
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Cysteine Aminoethylation Enables the Site-Specific Glycosylation Analysis of Recombinant Human Erythropoietin using Trypsin (2020 - Steffen Lippold, Alexander Büttner, Matthew S.F. Choo, Michaela Hook, Coen J. de Jong, Terry Nguyen-Khuong, Markus Haberger, Dietmar Reusch, Manfred Wuhrer, Noortje de Haan) / Status : Reviewed
- Primary Human Natural Killer Cells Retain Proinflammatory IgG1 at the Cell Surface and Express CD16a Glycoforms with Donor-dependent Variability. (2019 - Patel KR, Nott JD, Barb AW) / Status : Unreviewed
- Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4 (2014 - Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.) / Status : Reviewed
- Site-specific N-glycosylation analysis of human immunoglobulin E. (2014 - Plomp R, Hensbergen PJ, Rombouts Y, Zauner G, Dragan I, Koeleman CA, Deelder AM, Wuhrer M) / Status : Reviewed
- Determination of site-specific glycan heterogeneity on glycoproteins (2012 - Kolarich D1, Jensen PH, Altmann F, Packer NH.) / Status : Reviewed
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
- CD16A-NK08-V/F genotype / Homo sapiens
- CD16A-NK09-V/F genotype / Homo sapiens
- CD16A-NK11-F/F genotype / Homo sapiens
- CD16A-NK13-V/F genotype / Homo sapiens
- Erythropoietin / Homo sapiens
- Immunoglobulin epsilon chain c region / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- EAENITTGC (9aa)
- FHNESLISSQASSY (14aa)
- SLNENITVPDTK (12aa)
- GQALLVNSSQPWEPLQLHVDK (21aa)
- TQSLLIVNNATNVVIK (16aa)
- VYSSANNCTFE (11aa)
- CRGLVGSKNVSSE (13aa)
- TVNITITQGLA (11aa)
- NGTITDAVDCALDPLSE (17aa)
- AGCLIGAEHVNNSYE (15aa)
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Blood Serum (UBERON_0001977)
-
Alpha-1-acid glycoprotein 2 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Kidney (UBERON_0002113) BHK-21 (CVCL_1914)
- Kidney (UBERON_0002113) BHK570 (CVCL_6370) Fibroblast (CL_0000057)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Ovary (UBERON_0000992) CHO-DG44 (CVCL_7180)
- Human alpha-N-acetylgalactosaminidase: site occupancy and structure of N-linked oligosaccharides. (2000 - Ohta M, Ohnishi T, Ioannou Y, Hodgson M, Matsuura F, Desnick R) / Status : Reviewed
- Analysis of site-specific N-glycosylation of recombinant Desmodus rotundus salivary plasminogen activator rDSPA alpha 1 expressed in Chinese hamster ovary cells. (1997 - Gohlke M, Nuck R, Kannicht C, Grunow D, Baude G, Donner P, Reutter W) / Status : Reviewed
- Peptide, disulfide, and glycosylation mapping of recombinant human thrombopoietin from ser1 to Arg246. (1996 - Hoffman RC, Andersen H, Walker K, Krakover JD, Patel S, Stamm MR, Osborn SG) / Status : Reviewed
- A strategy for the mapping of N-glycans by high-performance capillary electrophoresis. (1994 - Hermentin P, Doenges R, Witzel R, Hokke C, Vliegenthart J, Kamerling J, Conradt H, Nimtz M, Brazel D) / Status : Reviewed
- Structural study of the N-linked oligosaccharides of hepatocyte growth factor by two-dimensional sugar mapping. (1993 - Hara H, Nakae Y, Sogabe T, Ihara I, Ueno S, Sakai H, Inoue H, Shimizu S, Nakamura T, Shimizu N) / Status : Reviewed
-
Alpha-n-acetylgalactosaminidase / Homo sapiens
- Undefined site
-
Erythropoietin / Homo sapiens
- Undefined site
- Hepatocyte growth factor / Homo sapiens
-
Thrombopoietin / Homo sapiens
- Undefined site
- Salivary plasminogen activator alpha 1 / Desmodus rotundus
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Eveline (CVCL_A1LI)
- Envelope glycoprotein / Friend murine leukemia virus
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- Salivary plasminogen activator alpha 1 / Desmodus rotundus
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
-
Erythropoietin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3100.8409)
-
Neuroligin 1 / Rattus norvegicus
- Undefined site
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
-
Erythropoietin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
-
Erythropoietin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Kidney (UBERON_0002113) BHK-21 (CVCL_1914)
-
Erythropoietin / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Milk (UBERON_0001913)
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Butyrophilin subfamily 1 member A1 / Homo sapiens
- Clusterin / Homo sapiens
- Haptoglobin / Homo sapiens
- RLSPNASAEHLELRW (15aa)
- KSVQEIQATFFYFTPNKT (18aa)
- KKKEDALNETRESETKL (17aa)
- KKKEDALNETRE (12aa)
- KNLFLNHSENATAKD (15aa)
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Neutrophil (CL_0000775)
-
- N-Linked / Complex
(avg mass : 3100.8409)
- HEK293T (CVCL_0063)
- Immunoglobulin epsilon chain c region / Homo sapiens
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Bone Marrow (UBERON_0002371)
-
- N-Linked / Complex
(avg mass : 3100.8409)
- HEK293 (CVCL_0045)
- COVID-19 (DOID:0080600)
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Blood Serum (UBERON_0001977)
- Control/Healthy
-
Alpha-1-acid glycoprotein 1 / Homo sapiens
- Undefined site
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Colon (UBERON_0001155)
-
- N-Linked / Complex
(avg mass : 3100.8409)
- Colon (UBERON_0001155)
-
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 / N-Linked
(avg mass : 3100.8409)
- Blood Serum (UBERON_0001977)
- Mammary Gland (UBERON_0001911)
- Seminal Fluid (UBERON_0006530)
- Urine (UBERON_0001088)
- FreeStyle 293-F (CVCL_D603)
- HEK293 (CVCL_0045)
- N-Linked / Complex / Structure 495
- N-Linked / Complex / Structure 1342
- N-Linked / Complex / Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-3)[Gal(b1-4)GlcNAc(?1-?)[Gal(b1-4)GlcNAc(?1-?)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)GlcNAc+"+ Fuc + 2 x NeuAc(a2-?)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ NeuAc(a2-?) + NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ Gal(b1-4)GlcNAc(b1-3) + 2 x NeuAc(a2-3)"
- N-Linked / Complex / Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)GlcNAc(b1-?)[Gal(b1-4)GlcNAc(b1-?)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc+"+ 2 x NeuAc(a2-3)"
- N-Linked / Complex / Hex(?1-?)HexNAc(?1-?)[Hex(?1-?)HexNAc(?1-?)]Man(a1-3)[Hex(?1-?)HexNAc(?1-?)[Hex(?1-?)HexNAc(?1-?)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(?1-?)]GlcNAc+"+ 2 x NeuAc"
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)[Gal(b1-4)GlcNAc(b1-2)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-2)[NeuAc(a2-3)Gal(b1-4)GlcNAc(b1-6)]Man(a1-6)[Gal(b1-4)GlcNAc(b1-2)[Gal(b1-4)GlcNAc(b1-4)]Man(a1-3)]Man(b1-4)GlcNAc(b1-4)[Fuc(a1-6)]GlcNAc
- N-Linked / Complex / Structure 9522
- N-Linked / Complex / Structure 10126
- N-Linked / Complex / Structure 10149
- N-Linked / Complex / Structure 10613
- N-Linked / Complex / Structure 10717
- N-Linked / Complex / Structure 10736
- N-Linked / Complex / Structure 11112
- N-Linked / Complex / Structure 11247
- Deducing the N- and O- glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2 (2020 - Asif Shajahan, Nitin T. Supekar, Anne S. Gleinich, Parastoo Azadi) / Status : Reviewed
- Site-specific glycan analysis of the SARS-CoV-2 spike (2020 - Yasunori Watanabe, Joel D. Allen, Daniel Wrapp, Jason S. McLellan, Max Crispin) / Status : Unreviewed
- Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and α-1B-Glycoprotein (2018 - Shisheng Sun, Yingwei Hu, Li Jia, Shadi Toghi Eshghi, Yang Liu, Punit Shah, Hui Zhang) / Status : Unreviewed
- Reanalysis of global proteomic and phosphoproteomic data identified a large number of glycopeptides (2018 - Yingwei Hu, Punit Shah, David J. Clark, Minghui Ao, Hui Zhang) / Status : Unreviewed
- Large-scale intact glycopeptide identification by Mascot database search (2018 - Ravi Chand Bollineni, Christian Jeffrey Koehler, Randi Elin Gislefoss, Jan Haug Anonsen, Bernd Thiede) / Status : Unreviewed
- Distinct urinary glycoprotein signatures in prostate cancer patients (2018 - Rebeca Kawahara, Fabio Ortega, Livia Rosa-Fernandes, Vanessa Guimarães, Daniel Quina, Willian Nahas, Veit Schwämmle, Miguel Srougi, Katia R.M. Leite, Morten Thaysen-Andersen, Martin R. Larsen and Giuseppe Palmisano) / Status : Unreviewed
- Selective glycopeptide profiling by acetone enrichment and LC/MS (2014 - Takakura D, Harazono A, Hashii N, Kawasaki N) / Status : Reviewed
- Glycoproteomics: Identifying the Glycosylation of Prostate Specific Antigen at Normal and High Isoelectric Points by LC-MS/MS (2014 - Song E, Mayampurath A, Yu CY, Tang H, Mechref Y) / Status : Reviewed
- 4F2 cell-surface antigen heavy chain / Homo sapiens
- Alpha-1-acid glycoprotein 1 / Homo sapiens
- Alpha-1-acid glycoprotein 2 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-mannosidase 2 / Homo sapiens
- Alpha-n-acetylglucosaminidase / Homo sapiens
- Aminopeptidase n / Homo sapiens
- Apolipoprotein D / Homo sapiens
- Apolipoprotein F / Homo sapiens
- Asporin / Homo sapiens
- Attractin / Homo sapiens
- BDNF/NT-3 growth factors receptor / Homo sapiens
- Biglycan / Homo sapiens
- CD166 antigen / Homo sapiens
- CD276 antigen / Homo sapiens
- CD44 antigen / Homo sapiens
- CD59 glycoprotein / Homo sapiens
- Cell adhesion molecule 1 / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Clusterin / Homo sapiens
- Complement c1r subcomponent / Homo sapiens
- Complement C1r subcomponent-like protein / Homo sapiens
- Decorin / Homo sapiens
- Desmocollin-2 / Homo sapiens
- Endothelin-converting enzyme 1 / Homo sapiens
- Epithelial cell adhesion molecule / Homo sapiens
- ERO1-like protein beta / Homo sapiens
- Extracellular matrix protein 1 / Homo sapiens
- Fibronectin / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
- Homeobox protein Hox-B3 / Homo sapiens
- Hypoxia up-regulated protein 1 / Homo sapiens
- Inactive tyrosine-protein kinase 7 / Homo sapiens
- Integrin alpha-L / Homo sapiens
- Kininogen-1 / Homo sapiens
- Lactotransferrin / Homo sapiens
- Laminin subunit alpha-5 / Homo sapiens
- Laminin subunit beta-1 / Homo sapiens
- Laminin subunit gamma-1 / Homo sapiens
- Leptin receptor / Homo sapiens
- Lumican / Homo sapiens
- Lysosome-associated membrane glycoprotein 1 / Homo sapiens
- Lysosome-associated membrane glycoprotein 2 / Homo sapiens
- Macrophage colony-stimulating factor 1 receptor / Homo sapiens
- Macrophage mannose receptor 1 / Homo sapiens
- Maltase-glucoamylase, intestinal / Homo sapiens
- Multimerin-1 / Homo sapiens
- Neural cell adhesion molecule L1-like protein / Homo sapiens
- P-selectin / Homo sapiens
- Plexin-B2 / Homo sapiens
- Prolactin-inducible protein / Homo sapiens
- Prolargin / Homo sapiens
- Prolow-density lipoprotein receptor-related protein 1 / Homo sapiens
- Prosaposin / Homo sapiens
- Prostaglandin F2 receptor negative regulator / Homo sapiens
- Prostaglandin-h2 d-isomerase / Homo sapiens
- Prostate-specific antigen - high Pi isoform (psah) / Homo sapiens
- Protein heg homolog 1 / Homo sapiens
- Protein-lysine 6-oxidase / Homo sapiens
- Receptor-type tyrosine-protein phosphatase kappa / Homo sapiens
- Secretogranin-3 / Homo sapiens
- Sodium/potassium-transporting ATPase subunit beta-1 / Homo sapiens
- T-cell immunomodulatory protein / Homo sapiens
- Target of Nesh-SH3 / Homo sapiens
- Tenascin / Homo sapiens
- Tenascin-X / Homo sapiens
- Thioredoxin domain-containing protein 15 / Homo sapiens
- Transcobalamin-1 / Homo sapiens
- Trem-like transcript 2 protein / Homo sapiens
- Tripeptidyl-peptidase 1 / Homo sapiens
- Tyrosine-protein kinase receptor UFO / Homo sapiens
- Uromodulin / Homo sapiens
- Versican core protein / Homo sapiens
- Voltage-dependent calcium channel subunit alpha-2/delta-1 / Homo sapiens
- Recombinant Spike glycoprotein (FreeStyle 293-F) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- LELNLTDSENATCLYAK (17aa)
- LVPVPITNATLDR (13aa)
- LVPVPITNATLDQITGK (17aa)
- TAVNCSSDFDACLITK (16aa)
- TAVNCSSDFDACIITK (16aa)
- AFNSTLPTMAQMEK (14aa)
- YETTNK (6aa)
- CIQANYSIMENGK (13aa)
- NKSVLLGR (8aa)
- SVQEIQATFFYFTPNKTEDTIFLR (24aa)
- YFTPNKTEDTIFLR (14aa)
- SVQEIQATFFYFTPNK (16aa)
- AEMNGSK (7aa)
- DSVINLSESVEDGPK (15aa)
- SVVAPATDGGLNLTSTFLR (19aa)
- DPGAAVPGAANASAQQPR (18aa)
- SSCGKENTSDPSIVIAFGR (19aa)
- AFENVTDLQWLILDHNLLENSK (22aa)
- GSNYTSK (7aa)
- VVNITMVALK (10aa)
- QNQCFYNSSYLNVQR (15aa)
- QDQCIYNTTYINVQR (15aa)
- QDQCIYNTTYLNVQR (15aa)
- ADGTVNQIEGEATPVNITEPAKIEVK (26aa)
- ADGTVNQIEGEATPVNLTEPAK (22aa)
- IAVQFGPGFSWIANFTK (17aa)
- FQIINFSSSEIK (12aa)
- TCDWIPKPNMSASCK (15aa)
- ELPGVCNETMMALWEECKPCLK (22aa)
- ELPGVCNETMMALWEECK (18aa)
- NDTLLGIK (8aa)
- TFYWDFYTNR (10aa)
- SANASFNIK (9aa)
- QGGVNATQVLIQHLR (15aa)
- MLLTFHTDFSNEENGTIMFYK (21aa)
- KLHINHNNLTESVGPLPK (18aa)
- LHINHNNLTESVGPLPK (17aa)
- ALSNISLR (8aa)
- TINQSSDEIQISMGNAMFVK (20aa)
- SELGAVIFWGQNQTLDPNNMTILNR (25aa)
- IGAINSTISNQSK (13aa)
- HTNYSFSPWHGFTIHR (16aa)
- GNFSTEGCGCVCEPGWK (17aa)
- NITGLENFTLK (11aa)
- SWPAVGNCSSALR (13aa)
- YNITSQDVGSGTSNNSQACAQFIEQYFHDSDIAQFMR (37aa)
- RYNLTSQDVGSGTSNNSQACAQFLEQYFHDSDLAQFMR (38aa)
- VVIGANGTYSCIVR (14aa)
- CNYSIR (6aa)
- LTVNSSNSIK (10aa)
- VEMANLLNLSER (12aa)
- VVLHPNYSQVDIGLIK (16aa)
- ISHNEIADSGIPGNSFNVSSIVEIDISYNK (30aa)
- ITNISSDDSGK (11aa)
- VFPQVNVTK (9aa)
- IININPNK (8aa)
- NAIKEGDNITIK (12aa)
- YIQPIIAVQFTNITMDTEIR (20aa)
- EGDNITIK (8aa)
- MIENGSISFIPTIR (14aa)
- LNSSTIK (7aa)
- NSSGPDLSWLHFYR (14aa)
- ITDIENGSIANIPR (14aa)
- YNENGTITDAVDCALDPLSETK (22aa)
- LNAENNATFYFK (12aa)
- NQSVNVFLGHTAIDEMLK (18aa)
- YIQVVYLHNNNISVVGSSDFCPPGHNTK (28aa)
- NATGDYK (7aa)
- NICHLR (6aa)
- NETLALPAESK (11aa)
- QDFNITDISLLEHR (14aa)
- INGTQICPNDIVAFHDFSSDIENVPHIR (28aa)
- FENQTGFPPPDSR (13aa)
- RFPNIT (6aa)
- NATDNISK (8aa)
- MNDTIFGFTMEER (13aa)
- IIIAGTNSSDIQQIISIIESNK (22aa)
- YKGLNLTEDTYKPR (14aa)
- VVNPTQK (7aa)
- VFHIHNESWVLLTPK (15aa)
- VNCSHPFGAFR (11aa)
- APQHVVNHLPPYTNVSLK (18aa)
- TAGWNIPMGIIFNQTGSCK (19aa)
- DQCIVDDITYNVNDTFHK (18aa)
- NGIYNITVLASDQGGR (16aa)
- YSVLIMAEKPVGDLSSPNETK (21aa)
- NSSVEAFK (8aa)
- NVTLLWK (7aa)
- NCMLNENMSVCVADFGLSK (19aa)
- IETILLNGTDR (11aa)
- ELHHLQEQNVSNAFLDK (17aa)
- LNDSIQTLVNDNQR (14aa)
- NATLVNEADK (10aa)
- NATIVNEADKIR (12aa)
- LSALDNLLNHSSMFLK (16aa)
- HLVNISVYAFNK (12aa)
- AATCINPINGSVCERPANHSAK (22aa)
- TQAALSNLTCCIDR (14aa)
- VPAQEKNFTTAPAICHDGKAHFPREGVF (28aa)
- NGTHWFV (7aa)
- EGVFVSNGTHWFVTQR (16aa)
- TLAGENQTAFEIEELNRK (18aa)
- LSDTTSQSNSTAK (13aa)
- VEAAQNITIPGSIR (14aa)
- IIETVEYNISGAER (14aa)
- QDPVSWDVAFVNISR (15aa)
- GFEESEPVSGSFTTAIDGPSGIVTANITDSEAIAR (35aa)
- AQQIIANSTAIEEAMIQEQQR (21aa)
- ALNLTEGFAVLHWK (14aa)
Source
Suggested structure
Reference
Reported glycosite
Mass spectrometry observed peptide
- Hex:7 HexNAc:6 dHex:1 NeuAc:2 / N-Linked
(avg mass : 3100.8409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Disease
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reference
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reference
Reported glycosite
Mass spectrometry observed peptide
- N-Linked / Complex
(avg mass : 3100.8409)
Source
Reported glycosite
- N-Linked / Complex
(avg mass : 3100.8409)